MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
ReWalk Robotics Ltd. Total Assets 2011-2026 | RWLK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets ReWalk Robotics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.9 M | 30.5 M | 63.2 M | 74.2 M | 94.8 M | 28.1 M | 24.4 M | 15 M | 22.9 M | 31.8 M | 25.6 M | 47.7 M | 11.1 M | 2.09 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.8 M | 2.09 M | 35.3 M |
Quarterly Total Assets ReWalk Robotics Ltd.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.2 M | 26.8 M | 28.8 M | 30.5 M | 45.8 M | 51 M | 55.2 M | 63.2 M | 69.2 M | 65.8 M | 69 M | 74.2 M | 80.8 M | 85.8 M | 90 M | 94.8 M | 98.7 M | 71.7 M | 74.6 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 15 M | 15 M | 15 M | 15 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 47.7 M | - | - | - | 11.1 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98.7 M | 11.1 M | 41.1 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 13.38 | 2.29 % | $ 1.81 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 25.74 | -1.0 % | $ 218 M | USA |
 |
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.28 | 1.86 % | $ 123 M |  France |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 90.74 | -3.16 % | $ 12.3 B | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | -1.96 % | $ 37.3 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.08 | -1.16 % | $ 314 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.08 | -1.89 % | $ 1.26 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.35 | 2.69 % | $ 64 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 61.29 | -3.34 % | $ 3.34 B |  Britain |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.91 | -3.33 % | $ 472 M |  Curacao |
 |
PAVmed
PAVM
|
38.8 M | $ 8.94 | 6.43 % | $ 5.99 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.23 | -4.3 % | $ 50 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 5.16 | -5.84 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.14 | -4.3 % | $ 355 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.55 | -2.68 % | $ 378 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.04 | -3.7 % | $ 17.6 M | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.15 | -8.51 % | $ 5.96 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.79 | -2.85 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 55.11 | 0.07 % | $ 1.62 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 84.64 | -0.83 % | $ 2.94 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 82.28 | -1.41 % | $ 48.1 B | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 321.43 | -2.3 % | $ 123 B | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 23.57 | -2.76 % | $ 539 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.78 | -2.46 % | $ 36.6 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.4 | 1.8 % | $ 502 M | USA |